Vaxart, Inc. Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment
Vaxart, Inc. (VXRT) had Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment of $13.59 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization
us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment · last filed 2026-08-06
- 2026-06-30: Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment $13.59M.
- 2026-03-31: Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment $14.56M.
- 2025-12-31: Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment $13.80M.
- 2025-09-30: Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment $12.99M.
| Period end | Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment as first filed |
|---|---|---|
| 2026-06-30 | $13.59M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $14.56M S-1 · filed 2026-05-08 | |
| 2025-12-31 | $13.80M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $12.99M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $12.31M 10-Q · filed 2025-08-13 | |
| 2025-03-31 | $11.42M 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $10.51M S-1 · filed 2026-05-08 | |
| 2024-09-30 | $9.59M 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $8.66M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $7.73M 10-Q · filed 2024-05-13 | |
| 2023-12-31 | $6.83M 10-K · filed 2025-03-20 | |
| 2023-09-30 | $5.94M 10-Q · filed 2023-11-02 | |
| 2023-06-30 | $5.11M 10-Q · filed 2023-08-03 | |
| 2023-03-31 | $4.17M 10-Q · filed 2023-05-04 | |
| 2022-12-31 | $3.27M 10-K · filed 2024-03-14 | |
| 2022-09-30 | $2.61M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $2.12M 10-Q · filed 2022-08-08 | |
| 2022-03-31 | $1.68M 10-Q · filed 2022-05-09 | |
| 2021-12-31 | $1.30M 10-K · filed 2023-03-15 | |
| 2021-09-30 | $979.00K 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $768.00K 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $648.00K 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $573.00K 10-K · filed 2022-02-24 | |
| 2020-09-30 | $537.00K 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $503.00K 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $478.00K 10-Q · filed 2020-05-12 | |
| 2019-12-31 | $459.00K 10-K · filed 2021-02-25 | |
| 2019-09-30 | $1.96M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $1.82M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $1.70M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $1.57M 10-K · filed 2020-03-19 | |
| 2018-09-30 | $1.52M 10-Q · filed 2018-11-13 | |
| 2018-06-30 | $1.46M 10-Q · filed 2018-08-10 | |
| 2018-03-31 | $1.33M 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $1.24M 10-K · filed 2019-02-06 | |
| 2017-06-30 | $400.00K 10-K · filed 2017-09-01 | |
| 2016-06-30 | $300.00K 10-K · filed 2017-09-01 | |
| 2015-06-30 | $200.00K 10-K · filed 2016-09-13 | |
| 2014-06-30 | $25.70M 10-K · filed 2015-09-11 | |
| 2013-06-30 | $23.10M 10-K · filed 2014-09-30 | $9.40M 10-K · filed 2013-09-27 |
| 2012-06-30 | $9.10M 10-K · filed 2013-09-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B |